Présentations en Congrès et Publications

DESCAR-T, Registre national des patients souffrant d’une hémopathie, éligibles à un traitement par cellules CAR-T

Accueil > LYSA > Parcourir les études cliniques en cours > DESCAR-T, Registre national des patients souffrant d’une hémopathie, éligibles à un traitement par cellules CAR-T > Présentations en Congrès et Publications

Publications 2022

Lysa 2022_LYSA_A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Manson, Guillaume Cartron, David Beauvais, Louise Roulin, François Xavier Gros, Marie Thérèse Rubio, Pierre Bories, Jacques Olivier Bay, Cristina Castilla Llorente, Sylvain Choquet, René-Olivier Casasnovas, Mohamad Mohty, Stéphanie Guidez, Magalie Joris, Michaël Loschi, Sylvain Carras, Julie Abraham, Adrien Chauchet, Laurianne Drieu La Rochelle, Bénédicte Deau-Fischer, Olivier Hermine, Thomas Gastinne, Jean Jacques Tudesq, Elodie Gat, Florence Broussais, Catherine Thieblemont, Roch Houot & Franck Morschhauser
doi: 10.1038/s41591-022-01969-y. En savoir plus
Lysa 2022_LYSA_Outcomes of patients with aggressive B-Cell lymphoma after failure of anti-CD19 CAR T-Cell Therapy. A DESCAR-T analysis
Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, René-Olivier Casanovas, Jacques-Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
doi: 10.1182/blood.2022016945. En savoir plus
Lysa 2022_LYSA_Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma
Clément Bailly, Thomas Carlier, Benoit Tessoulin, Thomas Gastinne, Françoise Kraeber-Bodere, Steven Le Gouill, Caroline Bodet-Milin
DOI: 10.1002/hon.2965 En savoir plus
Communication orale DESCAR-T EHA 2022
Emmanuel Bachy

A MATCHED COMPARISON OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL CAR T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-LIFE LYSA STUDY FROM THE FRENCH DESCAR-T REGISTRY

Plus d’infos sur le projet en cliquant ici
Communication orale DESCAR-T EHA 2022
Pierre Sesques

CAR T- CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-HODGKIN LYMPHOMA: REAL-WORLD STUDY FROM THE DESCAR-T REGISTRY
Communication orale DESCAR-T SFH 2022
F. Broussais / K. Danno

Retour d’expérience après 2 années de fonctionnement du registre DESCAR-T
Communication orale DESCAR-T EHA 2021
Steven Le Gouill

First results of DLBCL patients treated with CAR-T cells and enrolled in DESCAR-T registry, The French real-life database for CAR-T cells in hematologic malignancies

 

Abstract

 
Communication orale DESCAR-T ICM Lugano 2021
Steven Le Gouill

First results of DLBCL patients treated with CAR-T cells and enrolled in DESCAR-T registry, a French real-life database for CAR-T cells in hematologic malignancies

 

ICMLugano Steven Le Gouill Abstract N°084
Communication orale DESCAR-T SFH 2021
Emmanuel Bachy

Résultats de la cohorte lymphomes B diffus à grandes cellules traités par CAR-T du registre DESCAR-T (vie réelle)
Communication orale DESCAR-T ASH 2021
Roberta Di Blasi

Outcome of Relapsed/Refractory Aggressive B-Cell Lymphoma Patients Relapsing after Anti-CD19 CAR T-Cells and Enrolled in the Descar-T French National Registry
Blood | American Society of Hematology (ashpublications.org)
Communication orale DESCAR-T ASH 2021
Emmanuel Bachy

A Propensity Score-Matched Comparison of Axi-Cel and Tisa-Cel for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Real-Life: A Lysa Study from the Descar-T Registry
Blood | American Society of Hematology (ashpublications.org)
Communication orale DESCAR-T ASH 2021
Charles Herbaux

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a “Real-Life” Study from the Descar-T Registry and Lysa Group
Blood | American Society of Hematology (ashpublications.org)
Communication orale DESCAR-T SFGM-TC 2021
Steven Le Gouill

First results of DLBCL patients treated with CAR-T cells and enrolled in DESCAR-T registry, a French real-life database for CAR-T cells in hematologic malignancies

Publications 2021

Lysa 2021_LYSA_DESCAR-T, le registre national des patients traités par CAR-T Cells
Florence Broussais, Jacques Olivier Bay, Nicolas Boissel, André Baruchel, Bertrand Arnulf, Franck Morschhauser, Marie Robin, Gabrielle Roth Guepin, Philippe Moreau, Virginie Gandemer, Salomon Manier, Thibaut Leguay, Stéphanie Nguyen Quoc, Alexia Schwartzmann, Roch Houot, Steven Le Gouill
Bull Cancer . 2021 Oct;108(10S):S143-S154. En savoir plus
Lysa 2021_LYSA_A standardized medical report template for CAR T-Cell therapy patients: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Florence Broussais, Alyette Vasseur, Micheline Karam, Delphine Chaillou, Maguy Pereira, Ibrahim Yakoub-Agha, Nicole Raus
Bull Cancer . 2021 Dec;108(12S):S82-S86. En savoir plus